1-4 of 4
Teresa Wasielewska
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial Of Autologous CD19-Targeted CAR-Modified T Cells As Consolidation After Purine Analog-Based First-Line Therapy In Patients With Previously Untreated CLL

Jae H Park, MD, Isabelle Rivière, PhD, Xiuyan Wang, PhD, Jolanta Stefanski, Qing He, Oriana Borquez-Ojeda, Teresa Wasielewska, Clare Taylor, MSc, Jinrong Qu, Shirley Bartido, PhD, Yvette J Bernal, MS, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 874.
https://doi.org/10.1182/blood.V122.21.874.874
Published: 2013
Journal Articles

Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy

Marco L Davila, MD, PhD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Shirley Bartido, PhD, Jolanta Stefanski, Qing He, Oriana Borquez-Ojeda, Clare Taylor, MSc, Teresa Wasielewska, Jinrong Qu, Diana CG Bouhassira, BS, Yvette J Bernal, MS, Sarah Yoo, Terence Purdon, Elizabeth Halton, RN, MS, ANP, Hilda Quintanilla, RN, MS, ANP, Jae H Park, MD, Kevin J. Curran, MD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 69.
https://doi.org/10.1182/blood.V122.21.69.69
Published: 2013
Journal Articles

Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19–28z CAR-Targeted T Cells

Marco L Davila, MD, PhD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Jae H. Park, MD, Jolanta Stefanski, Clare Taylor, MSc, Qing He, Malgorzata Olszewska, Teresa Wasielewska, Oriana Borquez-Ojeda, Jinrong Qu, Shirley Bartido, PhD, Joseph G. Jurcic, MD, Dan Douer, MD, Mark G. Frattini, MD, PhD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3566.
https://doi.org/10.1182/blood.V120.21.3566.3566
Published: 2012
Journal Articles

Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL

Jae H. Park, MD, Isabelle Rivière, PhD, Xiuyan Wang, PhD, Jolanta Stefanski, Qing He, Clare Taylor, MSc, Malgorzata Olszewska, Teresa Wasielewska, Shirley Bartido, PhD, Marco L Davila, MD, PhD, Yvette Bernal, Nicole Lamanna, MD, Ariela Noy, MD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1797.
https://doi.org/10.1182/blood.V120.21.1797.1797
Published: 2012